Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

CME Group (CME) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

FinancialsFinancial Data & Stock ExchangesCME

Latest price · Nov 20, 2026 $311.15 +1.6% on the day · +17.4% over 12 months 52-week range $217.56 – $319.37
Get CME alerts
Open-market purchases1 insider$661K · last 12 months
Insiders selling14last 12 months
Reported sales$43.8M1 of 25 recent sales pre-planned (10b5-1)
In 15 seconds

Some insider buying ($661K), but sales were much larger ($43.8M) over the same 12 months.

Past insider buys here: 2 of 3 beat the S&P 500 over the next 90 days (small sample). See each one ↓

Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • 90-day result for William R. Shepard's $79K buy: in on Dec 27, 2026. See the 7- and 30-day results ↓
  • Next earnings expected around Jan 20, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale Terrence A. Duffy, CEO, Chair sold 17,000 shares at $310.18 ($5.3M).

Trade date
Nov 18, 2026
Disclosed to the SEC
Nov 19, 2026
Type
Sale (code S)

Read the original SEC filing ↗All CME insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

CME insider transactions (Form 4)

Open-market purchases and sales. 110 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Nov 19SEC Terrence A. DuffyCEO, Chair Sell 17,00035,442 held (−32%) $310.18 $5.3M +0.3% —
Nov 19SEC Terrence A. DuffyCEO, Chair Sell 10,00052,442 held (−16%) $308.54 $3.1M +0.8% —
Nov 19SEC John Clifford MarcheseGeneral Counsel Sell 6552,943 held (−18%) $310.75 $204K +0.1% —
Nov 10SEC Daniel G. KayeDirector Sell 5324,313 held (−11%) $304.17 $162K +2.3% —
Nov 3SEC Howard J. SiegelDirector Sell 2,00019,873 held (−9%) $303.00 $606K +2.7% —
Nov 2SEC Julie WinklerSr Md Chief Commercial Officer Sell 10,07921,482 held (−32%) $305.15 $3.1M +2.0% —
Oct 27SEC Sunil CutinhoChief Information Officer Sell 5,00020,037 held (−20%) $298.70 $1.5M +4.2% —
Oct 22SEC Martin J. GepsmanDirector Sell 40025,244 held (−2%) $302.50 $121K +2.9% —
Sep 28SEC William R. ShepardDirectorOff-schedule buyBefore earningsPast buys 9/19 beat S&P Buy 293263,289 held (+0%) $268.76 $79K +15.8% 45
Sep 14SEC Elizabeth A. CookDirector Sell 50017,916 held (−3%) $280.11 $140K +11.1% —
Sep 11SEC Terrence A. DuffyCEO, Chair Sell 14,37241,258 held (−26%) $274.41 $3.9M +13.4% —
Sep 11SEC Terrence A. DuffyCEO, Chair Sell 62840,630 held (−2%) $275.03 $173K +13.1% —
Jun 29SEC William R. ShepardDirectorRoutine (Jun buyer)Before earningsPast buys 9/19 beat S&P Buy 325260,442 held (+0%) $230.57 $75K +34.9% 45
Jun 29SEC William R. ShepardDirectorRoutine (Jun buyer)Before earningsPast buys 9/19 beat S&P Buy 143,621 held (+0%) $230.57 $3K +34.9% 45
May 19SEC Hilda Harris PiellSr Md & Chief Hr Officer Sell 5,75327,702 held (−17%) $304.63 $1.8M +2.1% —
May 18SEC Terrence A. DuffyCEO, Chair Sell 25,99664,634 held (−29%) $298.14 $7.8M +4.4% —
May 18SEC Terrence A. DuffyCEO, Chair Sell 9,00455,630 held (−14%) $299.58 $2.7M +3.9% —
Mar 30SEC William R. ShepardDirectorRoutine (Mar buyer)Past buys 9/19 beat S&P Buy 1,408260,118 held (+1%) $297.38 $419K +4.6% 45
Mar 30SEC William R. ShepardDirectorRoutine (Mar buyer)Past buys 9/19 beat S&P Buy 622,539 held (+3%) $297.38 $18K +4.6% 45
Mar 19SEC Jonathan L. MarcusGeneral Counsel Sell Plan 3,2917,192 held (−31%) $313.37 $1.0M -0.7% —
Mar 12SEC Ken VromanChief Transformation Officer Sell 5,16014,910 held (−26%) $309.00 $1.6M +0.7% —
Mar 9SEC Elizabeth A. CookDirector Sell 1,00017,771 held (−5%) $320.00 $320K -2.8% —
Feb 23SEC Bryan T. DurkinDirector Sell 4,20043,007 held (−9%) $309.65 $1.3M +0.5% —
Feb 20SEC Martin J. GepsmanDirector Sell 30024,999 held (−1%) $305.90 $92K +1.7% —
Feb 9SEC Dennis SuskindDirector Sell 7482,699 held (−22%) $300.00 $224K +3.7% —
Jan 2SEC William R. ShepardDirectorRoutine (Jan buyer)Before earningsPast buys 9/19 beat S&P Buy 251258,710 held (+0%) $278.37 $70K +11.8% 45
Jan 2SEC William R. ShepardDirectorRoutine (Jan buyer)Before earningsPast buys 9/19 beat S&P Buy 112,477 held (+0%) $278.37 $3K +11.8% 45
Dec 15SEC Terrence A. DuffyCEO, Chair Sell 13,08977,715 held (−14%) $269.10 $3.5M +15.6% —
Dec 15SEC Terrence A. DuffyCEO, Chair Sell 11,91165,804 held (−15%) $270.05 $3.2M +15.2% —
Nov 21SEC Derek SammannSr Md Gl Hd Commodities Mkts Sell 5,88611,028 held (−35%) $275.65 $1.6M +12.9% —
Nov 21SEC Derek SammannSr Md Gl Hd Commodities Mkts Sell 1,3147,022 held (−16%) $275.74 $362K +12.8% —
Nov 4SEC Harold Eugene Ford Jr.Director Sell 1,0001,091 held (−48%) $263.53 $264K +18.1% —
Historical context

Similar past setups: not applicable. There aren't enough comparable past cases for CME's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with CME in the Research Lab

Pre-set to CME's latest insider buy of $10K or more (Sep 28, 2026: William R. Shepard, $79K). Tap to change anything.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

CME closeInsider buyInsider sale
200250300350DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-04EEarnings release filed 2026-04-22EEarnings release filed 2026-07-22EEarnings release filed 2026-10-21Bought $73,008 on 2025-12-30 · William R. ShepardBought $78,186 on 2026-06-25 · William R. ShepardBought $78,626 on 2026-09-25 · William R. ShepardSold $91,770 on 2026-02-20 · Martin J. GepsmanSold $121,000 on 2026-10-22 · Martin J. GepsmanSold $140,055 on 2026-09-14 · Elizabeth A. CookSold $161,818 on 2026-11-09 · Daniel G. KayeSold $224,400 on 2026-02-06 · Dennis SuskindSold $320,000 on 2026-03-06 · Elizabeth A. CookBought $437,101 on 2026-03-26 · William R. ShepardSold $1,031,301 on 2026-03-17 · Jonathan L. MarcusSold $1,300,530 on 2026-02-23 · Bryan T. DurkinSold $1,493,500 on 2026-10-27 · Sunil CutinhoSold $1,594,440 on 2026-03-12 · Ken VromanSold $1,752,536 on 2026-05-18 · Hilda Harris PiellSold $1,984,798 on 2025-11-20 · Derek SammannSold $3,681,607 on 2026-11-02 · Howard J. Siegel, Julie WinklerSold $4,116,539 on 2026-09-10 · Terrence A. DuffySold $6,738,815 on 2025-12-11 · Terrence A. DuffySold $8,562,001 on 2026-11-18 · John Clifford Marchese, Terrence A. DuffySold $10,447,866 on 2026-05-15 · Terrence A. Duffy
Bought, 12 months$661K
Sold, 12 months$43.8M
Insiders buying1
Insiders selling14

CME Group insider trading at a glance (Nov 20, 2026): in the past 12 months, 1 insider bought $661K and 14 sold $43.8M of CME stock on the open market; P/E 26.1 vs. a sector median of 11.9.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

CME insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $73K bought (2 trades)$73KQ4 2025: $9.0M sold (5 trades)Q4 2025Q1 2026: $437K bought (2 trades)$437KQ1 2026: $4.6M sold (6 trades)Q1 2026Q2 2026: $78K bought (2 trades)$78KQ2 2026: $12.2M sold (3 trades)Q2 2026Q3 2026: $79K bought (1 trades)$79KQ3 2026: $4.3M sold (3 trades)Q3 2026Q4 2026: $14.0M sold (8 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$14.0M8
Q3 2026$79K1$4.3M3
Q2 2026$78K2$12.2M3
Q1 2026$437K2$4.6M6
Q4 2025$73K2$9.0M5

Valuation, profit and volume

P/E (trailing)26.1Sector median 11.9
Market value$114.13BFinancial Data & Stock Exchanges
Profit margin63.5%Revenue growth +13.0%
Volume vs. 50-day0.9×Last 5 sessions
Insiders' paper profit+$69KOn all tracked purchases +10.3%

Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 1 CME Group insider reported open-market purchases totaling $661K, while 14 insiders reported sales totaling $43.8M. Among insiders with enough purchase history to measure, William R. Shepard (Director) has the highest Insider Score at 45. 1 of 25 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

CME earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Oct 21, 2026 +9.4% Bought $79K +3.6%S&P -0.7% pending
Jul 22, 2026 +1.1% Bought $75K +7.1%S&P -1.3% +8.1%
Apr 22, 2026 -7.8% Bought $437K +0.4%S&P +0.6% +2.0%
Feb 4, 2026 +4.9% None +1.5%S&P -1.7% +6.6%
Oct 22, 2025 +2.5% None +0.1%S&P +0.1% +1.6%
Jul 23, 2025 -2.8% None +0.9%S&P +0.9% -2.8%
Apr 23, 2025 +5.2% None -0.9%S&P +3.7% +7.9%
Feb 12, 2025 +2.0% None +3.5%S&P +0.7% +3.9%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

CME short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 45% of volume sold short2026-08-27: 57% of volume sold short2026-08-28: 58% of volume sold short2026-08-31: 51% of volume sold short2026-09-01: 39% of volume sold short2026-09-02: 48% of volume sold short2026-09-03: 33% of volume sold short2026-09-04: 46% of volume sold short2026-09-08: 31% of volume sold short2026-09-09: 38% of volume sold short2026-09-10: 45% of volume sold short2026-09-11: 53% of volume sold short2026-09-14: 57% of volume sold short2026-09-15: 42% of volume sold short2026-09-16: 41% of volume sold short2026-09-17: 38% of volume sold short2026-09-18: 42% of volume sold short2026-09-21: 44% of volume sold short2026-09-22: 42% of volume sold short2026-09-23: 38% of volume sold short2026-09-24: 43% of volume sold short2026-09-25: 32% of volume sold short2026-09-28: 42% of volume sold short2026-09-29: 42% of volume sold short2026-09-30: 31% of volume sold short2026-10-01: 23% of volume sold short2026-10-02: 36% of volume sold short2026-10-05: 37% of volume sold short2026-10-06: 45% of volume sold short2026-10-07: 38% of volume sold short2026-10-08: 25% of volume sold short2026-10-09: 37% of volume sold short2026-10-12: 43% of volume sold short2026-10-13: 51% of volume sold short2026-10-14: 52% of volume sold short2026-10-15: 41% of volume sold short2026-10-16: 45% of volume sold short2026-10-19: 47% of volume sold short2026-10-20: 45% of volume sold short2026-10-21: 30% of volume sold short2026-10-22: 32% of volume sold short2026-10-23: 47% of volume sold short2026-10-26: 39% of volume sold short2026-10-27: 49% of volume sold short2026-10-28: 36% of volume sold short2026-10-29: 36% of volume sold short2026-10-30: 53% of volume sold short2026-11-02: 38% of volume sold short2026-11-03: 49% of volume sold short2026-11-04: 47% of volume sold short2026-11-05: 37% of volume sold short2026-11-06: 39% of volume sold short2026-11-09: 34% of volume sold short2026-11-10: 33% of volume sold short2026-11-11: 34% of volume sold short2026-11-12: 42% of volume sold short2026-11-13: 47% of volume sold short2026-11-16: 47% of volume sold short2026-11-17: 38% of volume sold short2026-11-18: 55% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 55%20-day average: 41%Prior 2 months: 40%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded CME

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 +7.0%

CME stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

What happened after CME insiders bought

Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.

Across all stocks →
FiledInsiderBought7 days30 days90 days
Sep 28, 2026William R. ShepardDirector$79K +2.6%+1.4% vs S&P+11.7%+10.8% vs S&Ppending
Jun 29, 2026William R. ShepardDirector$78K +7.4%+6.0% vs S&P+21.4%+23.0% vs S&P+21.0%+17.4% vs S&P
Mar 30, 2026William R. ShepardDirector$437K +3.7%-0.6% vs S&P-3.5%-16.1% vs S&P-26.2%-43.7% vs S&P
Jan 2, 2026William R. ShepardDirector$73K -2.7%-4.3% vs S&P+7.8%+6.0% vs S&P+15.8%+19.6% vs S&P

Insiders at CME Group

InsiderBoughtSoldLast filingPast buys beat S&PScore
Terrence A. DuffyCEO, Chair — $29.7M Nov 19, 2026 1 of 1 —
Julie WinklerSr Md Chief Commercial Officer — $3.1M Nov 2, 2026 — —
William R. ShepardDirector $667K — Sep 28, 2026 9 of 19 45
Derek SammannSr Md Gl Hd Commodities Mkts — $2.0M Sep 17, 2026 — —
Hilda Harris PiellSr Md & Chief Hr Officer — $1.8M May 19, 2026 — —
Ken VromanChief Transformation Officer — $1.6M Sep 17, 2026 — —
Sunil CutinhoChief Information Officer — $1.5M Oct 27, 2026 — —
Bryan T. DurkinDirector — $1.3M Jun 29, 2026 — —
Jonathan L. MarcusGeneral Counsel — $1.0M Mar 19, 2026 — —
Howard J. SiegelDirector — $606K Nov 3, 2026 — —
Elizabeth A. CookDirector — $460K Sep 14, 2026 — —
Harold Eugene Ford Jr.Director — $264K Jun 29, 2026 — —
Dennis SuskindDirector — $224K Jun 29, 2026 — —
Martin J. GepsmanDirector — $213K Oct 22, 2026 — —
John Clifford MarcheseGeneral Counsel — $204K Nov 19, 2026 — —
Daniel G. KayeDirector — $162K Nov 10, 2026 — —
Lynne FitzpatrickCFO, President — — Sep 17, 2026 — —
Suzanne SpragueCOO — — Sep 17, 2026 — —
Michael G. DennisGlobal Head Of Fixed Income — — Sep 17, 2026 — —
Timothy Francis McCourtSr Md Global Head Equity & Fx — — Sep 17, 2026 — —
Jack J. TobinMd Chief Accounting Officer — — Sep 17, 2026 — —
Deborah J. LucasDirector — — Jun 29, 2026 — —
Charles P. CareyDirector — — Jun 29, 2026 — —
Timothy S. BitsbergerDirector — — Jun 29, 2026 — —
William W. HobertDirector — — Jun 29, 2026 — —
Robert J. Tierney Jr.Director — — Jun 29, 2026 1 of 1 —
Phyllis M. LockettDirector — — Jun 29, 2026 — —
Patrick W. MaloneyDirector — — Jun 29, 2026 — —
Patrick J. MulchroneDirector — — Jun 29, 2026 — —
Rahael SeifuDirector — — Jun 29, 2026 — —
Kathryn BeneshDirector — — Jun 29, 2026 — —

Insider activity at other Financials companies

Same sector, ranked by insider buying in the last 90 days.

  • CRBGCorebridge Financial, Inc.$376M bought
  • BPREBluerock Private Real Estate Fund$42.6M bought
  • GLXYGalaxy Digital Inc.$15.1M bought
  • PMTSCPI Card Group Inc.$12.0M bought
  • GOLDGold.com, Inc.$11.8M bought
  • PSECPROSPECT CAPITAL CORP$10.5M bought

CME stock: common questions

Are CME Group insiders buying CME stock?

In the past 12 months, 1 insider reported open-market purchases of CME worth $661K. The latest was Director William R Shepard bought $79K of CME at $268.76.

Are CME Group insiders selling CME stock?

14 insiders reported sales worth $43.8M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is CME's P/E ratio?

CME trades at about 26.1 times trailing earnings, compared with a median of 11.9 for the Financials sector.

What is CME's 52-week range?

Over the past year CME has traded between $217.56 and $319.37. It last closed at $311.15 on Nov 20, 2026.